SUSQUEHANNA INTERNATIONAL GROUP, LLP - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 129 filers reported holding INTERSECT ENT INC in Q2 2017. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q1 2022$866,000
-80.2%
30,917
-80.7%
0.00%
Q4 2021$4,380,000
+78.3%
160,382
+77.6%
0.00%
Q3 2021$2,457,000
+145.7%
90,314
+54.3%
0.00%
Q2 2021$1,000,000
+210.6%
58,540
+280.1%
0.00%
Q1 2021$322,000
-33.5%
15,400
-27.1%
0.00%
Q4 2020$484,000
-48.2%
21,132
-73.2%
0.00%
Q1 2020$935,000
-60.4%
78,927
-16.9%
0.00%
-100.0%
Q4 2019$2,364,000
+424.2%
94,963
+257.9%
0.00%
Q3 2019$451,000
-95.3%
26,536
-93.7%
0.00%
Q2 2019$9,622,000
+342.0%
422,808
+524.5%
0.00%
-100.0%
Q1 2019$2,177,000
+1.4%
67,700
-11.2%
0.00%
Q4 2018$2,148,000
-44.5%
76,248
-43.4%
0.00%
-100.0%
Q3 2018$3,870,000
+537.6%
134,600
+730.9%
0.00%
Q2 2018$607,000
-44.5%
16,200
-41.7%
0.00%
Q1 2018$1,093,000
-57.2%
27,810
-64.7%
0.00%
-100.0%
Q4 2017$2,553,000
+270.5%
78,807
+256.6%
0.00%
Q3 2017$689,000
-75.6%
22,100
-78.1%
0.00%
-100.0%
Q2 2017$2,824,000
+111.1%
101,044
+29.5%
0.00%
Q1 2017$1,338,000
+178.2%
78,000
+96.1%
0.00%
Q4 2016$481,000
+101.3%
39,770
+274.3%
0.00%
Q4 2015$239,00010,6240.00%
Other shareholders
INTERSECT ENT INC shareholders Q2 2017
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 186,561$5,364,0004.51%
First Light Asset Management, LLC 517,121$14,867,0002.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,147,950$61,754,0002.21%
HealthCor Management, L.P. 1,950,000$56,063,0001.86%
PURA VIDA INVESTMENTS, LLC 200,000$5,750,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 112,000$2,469,0001.17%
Broadfin Capital, LLC 234,200$6,733,0000.99%
Lombard Odier Asset Management (USA) Corp 240,000$6,900,0000.51%
PURA VIDA INVESTMENTS, LLC 83,527$2,401,0000.50%
Rock Springs Capital Management LP 460,000$13,225,0000.48%
View complete list of INTERSECT ENT INC shareholders